EXHIBIT 23.2

                         CONSENT OF INDEPENDENT AUDITORS


We consent to the reference to our firm under the caption "Experts" in Amendment
No. 1 to the Registration Statement (Form S-3 No. 333-71086) and related
Prospectus of Peregrine Pharmaceuticals, Inc. for the registration of 10,000,000
shares of its common stock and warrants to purchase up to 2,000,000 shares of
its common stock, and to the incorporation by reference therein of our report
dated June 29, 2001, except for Notes 1 and 14, as to which the date is July 15,
2001, with respect to the consolidated financial statements and schedule of
Peregrine Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for
the year ended April 30, 2001, filed with the Securities and Exchange
Commission.



                                                          /s/ ERNST & YOUNG LLP



Orange County, California
November 2, 2001